Prof Steven Albelda: Novel Cancer Immunotherapy Clinical Trials: Beyond Checkpoint Blockade
Location:LEVEL 5 EDUCATION CENTRE CHRIS O’BRIEN LIFEHOUSE
Steven Albelda, MD, Professor of Medicine, Pulmonary, Allergy, and Critical Care Division, Perelman, School of Medicine, University of Pennsylvania
Dr Albelda is a Professor of Medicine at the Perelman School of Medicine at the University of Pennsylvania. He conducted his medical school and clinical internal medicine and pulmonary postgraduate training at Penn. Dr Albelda is the William Maul Measey Professor of Medicine, Vice Chief for Research in the Pulmonary Division, Director of the Thoracic Oncology Research Laboratory, and co-Director of the Translational Center of Excellence for Lung Cancer. Dr. Albelda has led an NCIfunded Program Project aimed at developing immune-gene therapy for thoracic cancers for the past 22 years. This has resulted in a series of Phase 1 and 2 clinical trials for patients with mesothelioma and lung cancer. The major areas of recent interest in the lab have been augmentation of anti-tumor immune effects, adoptive T cell transfer, and the tumor microenvironment.
Host: Dr Helen McGuire, ASI NSW Councillor
[email protected] email if you would also like to arrange a meeting